Risankizumab in very elderly patients in real-world practice
Ital J Dermatol Venerol
.
2024 Nov 7.
doi: 10.23736/S2784-8671.24.07941-6.
Online ahead of print.
Authors
Elisa Lorenzoni
1
,
Antonella DI Cesare
2
,
Elia Rosi
2
,
Emanuele Trovato
3
,
Leonardo Pescitelli
4
,
Salvatore Panduri
5
,
Federica Ricceri
6
,
Susanna Rossari
7
,
Michela Magnano
7
,
Imma Savarese
8
,
Gionata Buggiani
4
,
Barbara Simoni
1
,
Nicola Milanesi
8
,
Flavia Manzo Margiotta
5
9
,
Alessandra Michelucci
5
9
,
Eugenio Capalbo
3
,
Martina Dragotto
3
,
Marco Romanelli
5
,
Pietro Rubegni
3
,
Francesca Prignano
10
Affiliations
1
Unit of Dermatology, Hospital of Campo di Marte, Lucca, Italy.
2
Section of Dermatology, Department of Health Sciences, University of Florence, Florence, Italy.
3
Section of Dermatology, Department of Medical, Surgical and Neurological Science, University of Siena, Siena, Italy.
4
Unit of Dermatology, San Giuseppe Hospital, Empoli, Florence, Italy.
5
Department of Dermatology, University of Pisa, Pisa, Italy.
6
Unit of Dermatology, San Donato Hospital, Arezzo, Italy.
7
Unit of Dermatology, Versilia Hospital, Lido di Camaiore, Lucca, Italy.
8
Department of Dermatology, San Jacopo Hospital, Pistoia, Italy.
9
Interdisciplinary Center of Health Science, Sant'Anna School of Advanced Studies of Pisa, Pisa, Italy.
10
Section of Dermatology, Department of Health Sciences, University of Florence, Florence, Italy -
[email protected]
.
PMID:
39508830
DOI:
10.23736/S2784-8671.24.07941-6
No abstract available